In 2023, the US Food and Drug Administration (FDA) approved a record-breaking 61 drugs, the most in history. While it isn’t known whether 2024 might beat that record, it will surely be… Read More
Medical Foods Market Outlook
According to the report by Expert Market Research (EMR), the global medical foods market size is projected to grow at a CAGR of 6% between 2024 and 2032. Aided b… Read More
New York, United States, 2024-Apr-19— /EPR Network/ — “According to the research report published by Polaris Market Research, the Global Eosinophilic Esophagitis Drug Marke… Read More
New York, United States, 2024-Mar-18— /EPR Network/ — “According to the research report published by Polaris Market Research, the Global Eosinophilic Esophagitis Drug Marke… Read More
New York, United States, 2024-Feb-13 — /EPR Network/ — “According to the research report published by Polaris Market Research, the Global Eosinophilic Esophagitis Drug… Read More
New York, United States, 2024-Jan-11— /EPR Network/ — Polaris Market Research, a global market research firm, announces the release of the Eosinophilic Esophagitis Drug Market [r… Read More
In May, we reported on positive phase III trial data on dupilumab (Dupixent) for uncontrolled chronic obstructive pulmonary disease, a condition with no approved biologic therapy. In this… Read More
NEW YORK, United States, 2023-Oct-31 — /EPR Network/ — “According to the research report published by Polaris Market Research, the Global Eosinophilic Esophagitis Drug Mark… Read More
Delveinsight Business Research LLP
DelveInsight’s “Eosinophilic Esophagitis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth unders… Read More
DelveInsight’s “Eosinophilic Esophagitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Eosinophilic Esophagitis… Read More
On September 5, 2023, it was reported that Citigroup Inc. had increased its stake in Allakos Inc. by 32.5% during the first quarter of the year, according to a filing with the Securities and… Read More
Delveinsight Business Research LLP
DelveInsight’s “Eosinophilic Gastroenteritis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth un… Read More
In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More
When comparing Elecare vs Neocate vs PurAmino, many parents are stuck in choosing the best formula.
Seeing your baby grow in good health is a thing of joy, especially for mothers. The rig… Read More
Gastroenterology and hepatology diseases have a high global prevalence and disease burden in the U.S. To meet the growing need of patients worldwide, the global gastrointestinal (GI) drugs m… Read More
Dupixent is the first and only biologic that significantly improved skin clearance, and reduced itch and overall disease severity in children as young as 6 months old in a Phase 3 trial
P… Read More
Acquisition offers new, differentiated, and potentially best-in-class approach to address needs of a broader number of patients with immuno-inflammatory diseases
NEW YORK–(BUSINESS… Read More
In this report, the Global Eosinophilic Esophagitis Drug Market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% betwe… Read More
TARRYTOWN, N.Y. and PARIS, Sept. 21, 2021 /PRNewswire/ --
More than 30 presentations reinforce the role of Dupixent in targeting IL-4 and IL-13, key drivers of the type 2 inflammatio… Read More
Given that people have spent most of the past year being locked down at home due to the COVID-19 pandemic, it comes as no surprise that much of that time has been spent binging content on TV… Read More
We commonly encounter patients with wheat intolerances. When we explain disorder to them, they simply ask ‘I am taking wheat since childhood and how can it affect me now’? I will… Read More